Anoro®▼ Ellipta®

umeclidinium/vilanterol



Indication for Anoro® Ellipta®

Anoro® Ellipta® is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).1

References:

  1. Anoro Ellipta Summary of Product Characteristics, GlaxoSmithKline,Mar 2016

AB: Last Updated March 2016:
MLT_GIB/OTH/0001/15f